Identifying common transcriptome signatures of cancer by interpreting deep learning models, Genome Biology

Por um escritor misterioso
Last updated 08 junho 2024
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Background Cancer is a set of diseases characterized by unchecked cell proliferation and invasion of surrounding tissues. The many genes that have been genetically associated with cancer or shown to directly contribute to oncogenesis vary widely between tumor types, but common gene signatures that relate to core cancer pathways have also been identified. It is not clear, however, whether there exist additional sets of genes or transcriptomic features that are less well known in cancer biology but that are also commonly deregulated across several cancer types. Results Here, we agnostically identify transcriptomic features that are commonly shared between cancer types using 13,461 RNA-seq samples from 19 normal tissue types and 18 solid tumor types to train three feed-forward neural networks, based either on protein-coding gene expression, lncRNA expression, or splice junction use, to distinguish between normal and tumor samples. All three models recognize transcriptome signatures that are consistent across tumors. Analysis of attribution values extracted from our models reveals that genes that are commonly altered in cancer by expression or splicing variations are under strong evolutionary and selective constraints. Importantly, we find that genes composing our cancer transcriptome signatures are not frequently affected by mutations or genomic alterations and that their functions differ widely from the genes genetically associated with cancer. Conclusions Our results highlighted that deregulation of RNA-processing genes and aberrant splicing are pervasive features on which core cancer pathways might converge across a large array of solid tumor types.
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Deep transfer learning of cancer drug responses by integrating
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Splicing signature database development to delineate cancer
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Cancers, Free Full-Text
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Identifying common transcriptome signatures of cancer by
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Identifying functional regulatory mutation blocks by integrating
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Network analysis reveals rare disease signatures across multiple
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Network-based machine learning approach to predict immunotherapy
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Biology, Free Full-Text
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Identifying common transcriptome signatures of cancer by
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
The biological interpretation of deep neural network approach
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Cancers, Free Full-Text
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
PDF) Identifying common transcriptome signatures of cancer by
Identifying common transcriptome signatures of cancer by interpreting deep  learning models, Genome Biology
Deep learning model accurately classifies metastatic tumors from

© 2014-2024 empresaytrabajo.coop. All rights reserved.